FDA Seeks New Powers Over Drug Ads in 2026
The FDA is requesting expanded statutory authority over direct-to-consumer drug ads in its FY2027 budget, targeting misleading pharmaceutical promotions.
2 articles tagged "Fda Regulation"
The FDA is requesting expanded statutory authority over direct-to-consumer drug ads in its FY2027 budget, targeting misleading pharmaceutical promotions.
A four-month FDA meeting cancellation proved fatal for Kezar Life Sciences, highlighting how regulatory delays can devastate small biotech companies.